Key result
Hormonal contraceptives and hormone replacement therapy influence the risk of thromboembolic complications, with effects depending on drug components and dosages.
Why the study?
Does the use of hormonal contraceptives and hormone replacement therapy affect the risk of thromboembolic complications in women?
Does the use of hormonal contraceptives and hormone replacement therapy affect the risk of thromboembolic complications in women?
This review discusses the risk of thromboembolic complications associated with hormonal contraceptives and hormone replacement therapy, including strategies to reduce thrombogenic risk.
The review presents modern data of the effect of hormonal contraceptives and hormone replacement therapy drugs on the risk of thromboembolic complications. The effect of components of the drugs and their dosages on the hemostasis system is presented, the use of hormonal therapy in women with extragenital diseases is discussed, the ways of reducing the thrombogenic risk of hormones with their mandatory use are debated.
No takes yet. Share an insight, caveat, or question.
Melnikov et al. (2022) conducted a review in Thromboembolic complications. Hormonal contraceptives and hormone replacement therapy was evaluated on Thromboembolic complications. Hormonal contraceptives and hormone replacement therapy influence the risk of thromboembolic complications, with effects depending on drug components and dosages.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: